Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 80 | 2024 | 1046 | 6.070 |
Why?
|
Coronary Circulation | 72 | 2024 | 1577 | 5.720 |
Why?
|
Myocardium | 65 | 2024 | 4700 | 5.250 |
Why?
|
Myocardial Perfusion Imaging | 30 | 2023 | 571 | 4.590 |
Why?
|
Ventricular Remodeling | 36 | 2024 | 1261 | 4.100 |
Why?
|
Gadolinium DTPA | 41 | 2019 | 823 | 2.860 |
Why?
|
Contrast Media | 73 | 2023 | 5305 | 2.740 |
Why?
|
Magnetic Resonance Imaging | 131 | 2024 | 36290 | 2.630 |
Why?
|
Ventricular Function, Left | 57 | 2024 | 3880 | 2.210 |
Why?
|
Cardiomyopathies | 21 | 2024 | 1952 | 2.180 |
Why?
|
Heart | 25 | 2024 | 4393 | 1.930 |
Why?
|
Heart Diseases | 14 | 2023 | 2809 | 1.820 |
Why?
|
Fractional Flow Reserve, Myocardial | 9 | 2022 | 329 | 1.750 |
Why?
|
Gadolinium | 22 | 2023 | 959 | 1.690 |
Why?
|
Magnetic Resonance Angiography | 24 | 2017 | 1431 | 1.550 |
Why?
|
Fibrosis | 34 | 2024 | 2042 | 1.510 |
Why?
|
Myocardial Ischemia | 26 | 2023 | 2164 | 1.480 |
Why?
|
Coronary Artery Disease | 29 | 2023 | 6659 | 1.290 |
Why?
|
Stroke Volume | 47 | 2024 | 5523 | 1.260 |
Why?
|
Heart Ventricles | 25 | 2024 | 3811 | 1.230 |
Why?
|
Predictive Value of Tests | 63 | 2024 | 15289 | 1.210 |
Why?
|
Hyperemia | 10 | 2013 | 221 | 1.090 |
Why?
|
Hypertrophy, Left Ventricular | 10 | 2021 | 854 | 1.080 |
Why?
|
Aortic Valve Stenosis | 12 | 2024 | 2065 | 1.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 14 | 2022 | 1311 | 1.050 |
Why?
|
Cardiovascular System | 2 | 2023 | 850 | 1.010 |
Why?
|
Image Enhancement | 25 | 2021 | 2881 | 0.950 |
Why?
|
Myocardial Infarction | 24 | 2024 | 11891 | 0.840 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2019 | 819 | 0.820 |
Why?
|
Cardiac Imaging Techniques | 6 | 2021 | 269 | 0.810 |
Why?
|
Anthracyclines | 4 | 2023 | 283 | 0.800 |
Why?
|
Coronary Stenosis | 10 | 2016 | 820 | 0.780 |
Why?
|
Pericardium | 5 | 2018 | 675 | 0.760 |
Why?
|
Image Interpretation, Computer-Assisted | 18 | 2019 | 3340 | 0.750 |
Why?
|
Ventricular Dysfunction, Left | 15 | 2019 | 2128 | 0.740 |
Why?
|
Exercise Test | 17 | 2024 | 2128 | 0.730 |
Why?
|
Transposition of Great Vessels | 4 | 2018 | 590 | 0.720 |
Why?
|
Myocytes, Cardiac | 6 | 2018 | 1657 | 0.720 |
Why?
|
Heart Failure | 19 | 2024 | 11847 | 0.700 |
Why?
|
Atherosclerosis | 18 | 2024 | 3517 | 0.690 |
Why?
|
Aorta, Thoracic | 8 | 2016 | 1097 | 0.690 |
Why?
|
Coronary Angiography | 24 | 2020 | 4563 | 0.680 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2024 | 615 | 0.670 |
Why?
|
Ventricular Dysfunction | 4 | 2021 | 145 | 0.660 |
Why?
|
Magnetic Resonance Spectroscopy | 13 | 2023 | 3765 | 0.660 |
Why?
|
Ethylene Glycols | 4 | 2024 | 190 | 0.630 |
Why?
|
Amyloidosis | 5 | 2021 | 817 | 0.620 |
Why?
|
Spironolactone | 3 | 2023 | 411 | 0.620 |
Why?
|
Myocardial Contraction | 11 | 2014 | 1516 | 0.610 |
Why?
|
Myocarditis | 6 | 2022 | 766 | 0.600 |
Why?
|
Echocardiography, Doppler | 8 | 2021 | 901 | 0.590 |
Why?
|
Perfusion | 9 | 2023 | 1376 | 0.590 |
Why?
|
Microcirculation | 9 | 2021 | 1278 | 0.580 |
Why?
|
Humans | 256 | 2024 | 760621 | 0.580 |
Why?
|
Tetralogy of Fallot | 4 | 2019 | 631 | 0.570 |
Why?
|
Coronary Disease | 18 | 2009 | 5990 | 0.570 |
Why?
|
Hypertension | 8 | 2024 | 8594 | 0.540 |
Why?
|
Image Processing, Computer-Assisted | 28 | 2021 | 8950 | 0.540 |
Why?
|
Coronary Vessels | 11 | 2018 | 3112 | 0.530 |
Why?
|
Immunoglobulin Light Chains | 3 | 2024 | 286 | 0.530 |
Why?
|
Fatty Liver | 3 | 2017 | 778 | 0.520 |
Why?
|
Atrial Function, Left | 6 | 2018 | 186 | 0.510 |
Why?
|
Extracellular Matrix | 5 | 2017 | 1726 | 0.510 |
Why?
|
Vasodilator Agents | 9 | 2014 | 978 | 0.510 |
Why?
|
Organometallic Compounds | 11 | 2019 | 662 | 0.510 |
Why?
|
Exercise Tolerance | 7 | 2024 | 830 | 0.500 |
Why?
|
Regional Blood Flow | 12 | 2019 | 1490 | 0.490 |
Why?
|
Cardiomegaly | 2 | 2016 | 593 | 0.490 |
Why?
|
Middle Aged | 130 | 2024 | 220352 | 0.490 |
Why?
|
Body Water | 2 | 2013 | 341 | 0.480 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2024 | 164 | 0.480 |
Why?
|
Male | 165 | 2024 | 359744 | 0.480 |
Why?
|
Prognosis | 42 | 2024 | 29658 | 0.470 |
Why?
|
Aniline Compounds | 4 | 2024 | 1069 | 0.460 |
Why?
|
Microspheres | 7 | 2012 | 787 | 0.460 |
Why?
|
Adenosine | 8 | 2015 | 834 | 0.450 |
Why?
|
Microvascular Angina | 4 | 2018 | 14 | 0.440 |
Why?
|
Female | 161 | 2024 | 391270 | 0.440 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2024 | 1387 | 0.440 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1303 | 0.430 |
Why?
|
Amyloid | 2 | 2018 | 842 | 0.430 |
Why?
|
Adiposity | 4 | 2017 | 1858 | 0.420 |
Why?
|
Endomyocardial Fibrosis | 1 | 2012 | 41 | 0.420 |
Why?
|
Aged | 101 | 2024 | 169152 | 0.420 |
Why?
|
Ventricular Fibrillation | 1 | 2015 | 539 | 0.410 |
Why?
|
Artificial Intelligence | 5 | 2022 | 2557 | 0.410 |
Why?
|
Ventriculography, First-Pass | 4 | 2013 | 20 | 0.400 |
Why?
|
Tomography, X-Ray Computed | 17 | 2019 | 20509 | 0.400 |
Why?
|
Prealbumin | 1 | 2014 | 222 | 0.400 |
Why?
|
Heart Atria | 7 | 2021 | 1346 | 0.400 |
Why?
|
Hypoplastic Left Heart Syndrome | 5 | 2021 | 594 | 0.400 |
Why?
|
Atrial Fibrillation | 11 | 2024 | 5209 | 0.400 |
Why?
|
Prospective Studies | 48 | 2024 | 54303 | 0.400 |
Why?
|
Sensitivity and Specificity | 30 | 2014 | 14660 | 0.390 |
Why?
|
Models, Cardiovascular | 9 | 2009 | 978 | 0.380 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2014 | 150 | 0.380 |
Why?
|
Blood Flow Velocity | 8 | 2019 | 1377 | 0.380 |
Why?
|
Oxygen Consumption | 7 | 2019 | 1843 | 0.370 |
Why?
|
Sarcomeres | 3 | 2021 | 367 | 0.370 |
Why?
|
Reproducibility of Results | 27 | 2022 | 20080 | 0.370 |
Why?
|
Collateral Circulation | 4 | 2007 | 292 | 0.370 |
Why?
|
Phenotype | 8 | 2024 | 16546 | 0.360 |
Why?
|
Iron | 2 | 2015 | 1786 | 0.360 |
Why?
|
Tissue Survival | 3 | 2008 | 119 | 0.350 |
Why?
|
Coronary Artery Bypass | 3 | 2022 | 2272 | 0.350 |
Why?
|
Adipose Tissue | 3 | 2017 | 3301 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 10 | 2016 | 4048 | 0.350 |
Why?
|
Capillary Permeability | 2 | 2014 | 768 | 0.340 |
Why?
|
Ventricular Function, Right | 7 | 2019 | 610 | 0.340 |
Why?
|
Edema | 1 | 2014 | 769 | 0.340 |
Why?
|
Linear Models | 16 | 2017 | 5877 | 0.330 |
Why?
|
Death, Sudden, Cardiac | 6 | 2023 | 1572 | 0.320 |
Why?
|
Swine | 17 | 2014 | 5899 | 0.310 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.310 |
Why?
|
Time Factors | 32 | 2024 | 40165 | 0.310 |
Why?
|
Aorta | 5 | 2020 | 2039 | 0.310 |
Why?
|
Systole | 11 | 2016 | 947 | 0.310 |
Why?
|
Myocardial Reperfusion | 4 | 2021 | 347 | 0.310 |
Why?
|
Heart Defects, Congenital | 10 | 2019 | 4673 | 0.300 |
Why?
|
Radiopharmaceuticals | 6 | 2024 | 2634 | 0.300 |
Why?
|
Cardiac Surgical Procedures | 4 | 2016 | 3620 | 0.300 |
Why?
|
Tomography | 2 | 2019 | 411 | 0.300 |
Why?
|
Obesity | 6 | 2016 | 12922 | 0.290 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2023 | 675 | 0.280 |
Why?
|
Retinal Artery | 1 | 2007 | 109 | 0.280 |
Why?
|
Microvessels | 3 | 2018 | 572 | 0.280 |
Why?
|
Risk Factors | 42 | 2024 | 74359 | 0.280 |
Why?
|
Adult | 72 | 2024 | 219994 | 0.280 |
Why?
|
Electrocardiography | 15 | 2017 | 6414 | 0.280 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2024 | 1717 | 0.280 |
Why?
|
Meglumine | 5 | 2019 | 145 | 0.280 |
Why?
|
Sports | 2 | 2022 | 700 | 0.270 |
Why?
|
Pulmonary Veins | 4 | 2014 | 745 | 0.270 |
Why?
|
Cardiovascular Diseases | 13 | 2021 | 15757 | 0.260 |
Why?
|
Heart Transplantation | 7 | 2024 | 3224 | 0.260 |
Why?
|
Arrhythmias, Cardiac | 7 | 2023 | 2255 | 0.240 |
Why?
|
Reference Values | 12 | 2020 | 4925 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2019 | 3959 | 0.240 |
Why?
|
Echocardiography | 17 | 2024 | 4981 | 0.240 |
Why?
|
Embolism, Air | 1 | 2004 | 110 | 0.230 |
Why?
|
Myocardial Revascularization | 4 | 2005 | 841 | 0.230 |
Why?
|
Age Factors | 12 | 2020 | 18416 | 0.230 |
Why?
|
Cardiac Output, Low | 1 | 2004 | 192 | 0.230 |
Why?
|
Case-Control Studies | 20 | 2021 | 22053 | 0.230 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2014 | 260 | 0.220 |
Why?
|
Aging | 4 | 2020 | 8651 | 0.220 |
Why?
|
Peptide Fragments | 5 | 2024 | 5125 | 0.210 |
Why?
|
Weight Loss | 1 | 2014 | 2686 | 0.210 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39261 | 0.200 |
Why?
|
Liver | 2 | 2019 | 7509 | 0.200 |
Why?
|
Catheter Ablation | 6 | 2021 | 2758 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2016 | 18137 | 0.200 |
Why?
|
Arteritis | 1 | 2024 | 162 | 0.200 |
Why?
|
Chi-Square Distribution | 7 | 2017 | 3465 | 0.190 |
Why?
|
Radiographic Image Enhancement | 3 | 2007 | 875 | 0.190 |
Why?
|
Algorithms | 9 | 2014 | 13981 | 0.190 |
Why?
|
Sympathetic Nervous System | 1 | 2024 | 520 | 0.190 |
Why?
|
Risk Assessment | 17 | 2024 | 24123 | 0.190 |
Why?
|
Extracellular Space | 3 | 2013 | 564 | 0.180 |
Why?
|
Edema, Cardiac | 2 | 2017 | 19 | 0.180 |
Why?
|
Doxorubicin | 2 | 2018 | 2209 | 0.180 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2010 | 1067 | 0.180 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 77 | 0.180 |
Why?
|
Cicatrix | 3 | 2022 | 782 | 0.180 |
Why?
|
Collagen | 2 | 2013 | 2636 | 0.170 |
Why?
|
Diastole | 6 | 2014 | 788 | 0.170 |
Why?
|
Young Adult | 22 | 2023 | 58741 | 0.170 |
Why?
|
Benzylamines | 1 | 2020 | 248 | 0.170 |
Why?
|
Molecular Imaging | 2 | 2023 | 818 | 0.170 |
Why?
|
Severity of Illness Index | 16 | 2024 | 15840 | 0.170 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 102 | 0.170 |
Why?
|
Uracil | 1 | 2020 | 207 | 0.160 |
Why?
|
Animals | 34 | 2020 | 167963 | 0.160 |
Why?
|
HIV Infections | 5 | 2024 | 17165 | 0.160 |
Why?
|
Aged, 80 and over | 24 | 2022 | 58995 | 0.160 |
Why?
|
Artifacts | 5 | 2010 | 1898 | 0.160 |
Why?
|
Pulmonary Artery | 3 | 2017 | 1921 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2004 | 1599 | 0.160 |
Why?
|
Positron-Emission Tomography | 5 | 2019 | 6465 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2024 | 65017 | 0.150 |
Why?
|
Elasticity | 5 | 2015 | 652 | 0.150 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 867 | 0.150 |
Why?
|
Intra-Abdominal Fat | 4 | 2015 | 608 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2021 | 12293 | 0.150 |
Why?
|
Cardiac Volume | 3 | 2013 | 199 | 0.140 |
Why?
|
Oxygen | 3 | 2021 | 4193 | 0.140 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 413 | 0.140 |
Why?
|
American Heart Association | 3 | 2022 | 1081 | 0.140 |
Why?
|
Proportional Hazards Models | 10 | 2017 | 12531 | 0.140 |
Why?
|
Hemodynamics | 12 | 2016 | 4174 | 0.140 |
Why?
|
Body Surface Potential Mapping | 1 | 2018 | 228 | 0.140 |
Why?
|
Observer Variation | 5 | 2013 | 2601 | 0.140 |
Why?
|
HIV | 2 | 2023 | 1579 | 0.140 |
Why?
|
Mitral Valve Prolapse | 1 | 2018 | 215 | 0.140 |
Why?
|
Electric Impedance | 1 | 2001 | 755 | 0.140 |
Why?
|
Adiponectin | 2 | 2019 | 1115 | 0.130 |
Why?
|
Chagas Cardiomyopathy | 1 | 2016 | 71 | 0.130 |
Why?
|
Aortic Coarctation | 2 | 2016 | 282 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2017 | 278 | 0.130 |
Why?
|
Sex Factors | 8 | 2017 | 10547 | 0.130 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3527 | 0.130 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2014 | 140 | 0.130 |
Why?
|
Carotid Artery, Common | 1 | 2016 | 177 | 0.130 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 458 | 0.130 |
Why?
|
Norwood Procedures | 1 | 2017 | 192 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 322 | 0.130 |
Why?
|
Oxides | 1 | 1997 | 401 | 0.130 |
Why?
|
Pilot Projects | 9 | 2024 | 8555 | 0.130 |
Why?
|
Aortic Valve | 2 | 2024 | 1996 | 0.130 |
Why?
|
Disease Progression | 10 | 2019 | 13502 | 0.120 |
Why?
|
Computer Simulation | 5 | 2009 | 6218 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2017 | 743 | 0.120 |
Why?
|
Pentetic Acid | 6 | 1997 | 209 | 0.120 |
Why?
|
Monocytes | 2 | 2022 | 2575 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2014 | 187 | 0.120 |
Why?
|
United States | 18 | 2022 | 72461 | 0.120 |
Why?
|
Fish Oils | 1 | 2018 | 482 | 0.120 |
Why?
|
Body Fat Distribution | 1 | 2015 | 243 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2022 | 2414 | 0.120 |
Why?
|
Fontan Procedure | 3 | 2019 | 791 | 0.110 |
Why?
|
Leptin | 2 | 2019 | 1591 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1898 | 0.110 |
Why?
|
Abdominal Fat | 1 | 2015 | 223 | 0.110 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12159 | 0.110 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2024 | 1582 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2017 | 14495 | 0.110 |
Why?
|
Albuminuria | 2 | 2015 | 659 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1997 | 479 | 0.110 |
Why?
|
Asymptomatic Diseases | 4 | 2019 | 587 | 0.110 |
Why?
|
Random Allocation | 4 | 2013 | 2394 | 0.110 |
Why?
|
Fibroblasts | 1 | 2023 | 4090 | 0.110 |
Why?
|
Dogs | 9 | 2008 | 3841 | 0.110 |
Why?
|
Organ Size | 6 | 2016 | 2254 | 0.110 |
Why?
|
Endocardium | 2 | 2011 | 246 | 0.110 |
Why?
|
Incidence | 9 | 2017 | 21392 | 0.110 |
Why?
|
Porosity | 1 | 1994 | 349 | 0.110 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 822 | 0.110 |
Why?
|
Chest Pain | 1 | 2020 | 1106 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5889 | 0.110 |
Why?
|
Adolescent | 22 | 2020 | 87810 | 0.100 |
Why?
|
Heart Rate | 3 | 2019 | 4179 | 0.100 |
Why?
|
Triglycerides | 3 | 2016 | 2476 | 0.100 |
Why?
|
Papillary Muscles | 2 | 2018 | 192 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2008 | 613 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1182 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1398 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 374 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 516 | 0.100 |
Why?
|
Retrospective Studies | 19 | 2023 | 80372 | 0.100 |
Why?
|
Ferrosoferric Oxide | 2 | 2007 | 348 | 0.100 |
Why?
|
Hypertrophy | 1 | 2013 | 555 | 0.100 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.100 |
Why?
|
Body Mass Index | 9 | 2016 | 12914 | 0.090 |
Why?
|
Child | 17 | 2023 | 79806 | 0.090 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 25942 | 0.090 |
Why?
|
Physical Fitness | 1 | 2016 | 732 | 0.090 |
Why?
|
Injections, Intravenous | 4 | 2018 | 1385 | 0.090 |
Why?
|
Blood Pressure | 7 | 2020 | 8525 | 0.090 |
Why?
|
Vascular Resistance | 2 | 2015 | 933 | 0.090 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 265 | 0.090 |
Why?
|
C-Reactive Protein | 4 | 2015 | 3839 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2365 | 0.090 |
Why?
|
Rheology | 2 | 2009 | 348 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2008 | 1880 | 0.090 |
Why?
|
Feasibility Studies | 7 | 2014 | 5201 | 0.090 |
Why?
|
Foundations | 1 | 2010 | 97 | 0.090 |
Why?
|
Carotid Arteries | 1 | 2014 | 951 | 0.090 |
Why?
|
Child, Preschool | 13 | 2021 | 42063 | 0.090 |
Why?
|
Registries | 4 | 2022 | 8469 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2013 | 6238 | 0.080 |
Why?
|
Mutation | 4 | 2017 | 29932 | 0.080 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2010 | 96 | 0.080 |
Why?
|
Phantoms, Imaging | 3 | 2022 | 2512 | 0.080 |
Why?
|
Postoperative Care | 1 | 2016 | 1479 | 0.080 |
Why?
|
Spinal Canal | 1 | 2009 | 41 | 0.080 |
Why?
|
Smoking | 5 | 2012 | 9073 | 0.080 |
Why?
|
Tricuspid Valve | 2 | 2009 | 409 | 0.080 |
Why?
|
Health Status Disparities | 2 | 2017 | 1830 | 0.080 |
Why?
|
England | 3 | 2017 | 526 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2015 | 698 | 0.080 |
Why?
|
Diet, Mediterranean | 1 | 2015 | 735 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2102 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 577 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 1419 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2009 | 319 | 0.080 |
Why?
|
Neovascularization, Physiologic | 3 | 2006 | 1336 | 0.080 |
Why?
|
Aldosterone | 1 | 2013 | 868 | 0.080 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2007 | 14 | 0.080 |
Why?
|
Inflammation Mediators | 2 | 2014 | 1881 | 0.080 |
Why?
|
Double-Blind Method | 5 | 2023 | 12427 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2010 | 510 | 0.070 |
Why?
|
Mice | 5 | 2020 | 81208 | 0.070 |
Why?
|
Prevalence | 7 | 2022 | 15687 | 0.070 |
Why?
|
Radioisotopes | 1 | 2008 | 495 | 0.070 |
Why?
|
Pulsatile Flow | 1 | 2008 | 321 | 0.070 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1475 | 0.070 |
Why?
|
Vasodilation | 3 | 2007 | 962 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2014 | 878 | 0.070 |
Why?
|
Ligation | 2 | 2004 | 448 | 0.070 |
Why?
|
Area Under Curve | 3 | 2017 | 1636 | 0.070 |
Why?
|
Neoplasms | 2 | 2012 | 22072 | 0.070 |
Why?
|
ROC Curve | 4 | 2017 | 3568 | 0.070 |
Why?
|
Rest | 3 | 2007 | 914 | 0.070 |
Why?
|
Inflammation | 3 | 2016 | 10756 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2016 | 1499 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2010 | 360 | 0.070 |
Why?
|
Heterocyclic Compounds | 1 | 2007 | 247 | 0.070 |
Why?
|
Exercise | 2 | 2020 | 5787 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1008 | 0.070 |
Why?
|
Retinal Diseases | 2 | 2012 | 702 | 0.060 |
Why?
|
Advisory Committees | 1 | 2010 | 788 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 544 | 0.060 |
Why?
|
Recovery of Function | 4 | 2019 | 2985 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6544 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 553 | 0.060 |
Why?
|
Myocardial Stunning | 1 | 2005 | 66 | 0.060 |
Why?
|
Laser Therapy | 2 | 2004 | 1089 | 0.060 |
Why?
|
Motion | 1 | 1989 | 779 | 0.060 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 974 | 0.060 |
Why?
|
Electrodes | 2 | 2014 | 614 | 0.060 |
Why?
|
Polylysine | 2 | 1996 | 131 | 0.060 |
Why?
|
Blood Glucose | 3 | 2016 | 6381 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2006 | 354 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10551 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2010 | 822 | 0.060 |
Why?
|
Societies, Medical | 2 | 2022 | 3905 | 0.060 |
Why?
|
Constriction | 1 | 2004 | 172 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 426 | 0.060 |
Why?
|
Animal Experimentation | 1 | 2004 | 46 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2916 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 994 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2640 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 408 | 0.060 |
Why?
|
Enalapril | 2 | 2017 | 313 | 0.060 |
Why?
|
Cohort Studies | 8 | 2017 | 41335 | 0.060 |
Why?
|
Respiration | 3 | 2019 | 1654 | 0.060 |
Why?
|
Absorbable Implants | 1 | 2006 | 345 | 0.060 |
Why?
|
Equipment Design | 4 | 2014 | 3520 | 0.060 |
Why?
|
3-Iodobenzylguanidine | 1 | 2024 | 114 | 0.060 |
Why?
|
Radionuclide Imaging | 3 | 2024 | 1975 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1215 | 0.050 |
Why?
|
Leadership | 2 | 2022 | 1371 | 0.050 |
Why?
|
Autopsy | 1 | 2007 | 1007 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3113 | 0.050 |
Why?
|
Tomography, Emission-Computed | 2 | 2012 | 1121 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2004 | 948 | 0.050 |
Why?
|
Blood Volume | 4 | 1999 | 550 | 0.050 |
Why?
|
Waist Circumference | 2 | 2016 | 926 | 0.050 |
Why?
|
Troponin T | 2 | 2018 | 774 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12965 | 0.050 |
Why?
|
Subcutaneous Fat | 2 | 2015 | 393 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3531 | 0.050 |
Why?
|
Ventricular Function | 1 | 2004 | 408 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2010 | 1958 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2024 | 461 | 0.050 |
Why?
|
Infant | 7 | 2019 | 36060 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1489 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2004 | 377 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 210 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2002 | 320 | 0.050 |
Why?
|
Diabetes Complications | 2 | 2006 | 1341 | 0.050 |
Why?
|
Renin | 1 | 2023 | 635 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2024 | 2007 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 4081 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 380 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 302 | 0.050 |
Why?
|
Troponin | 1 | 2004 | 516 | 0.050 |
Why?
|
Dilatation, Pathologic | 2 | 2015 | 527 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1860 | 0.040 |
Why?
|
Anti-Retroviral Agents | 2 | 2020 | 1779 | 0.040 |
Why?
|
Graft Survival | 2 | 2016 | 3794 | 0.040 |
Why?
|
Cryopreservation | 1 | 2005 | 717 | 0.040 |
Why?
|
Logistic Models | 4 | 2016 | 13314 | 0.040 |
Why?
|
Angina Pectoris | 2 | 2018 | 969 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3334 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2001 | 376 | 0.040 |
Why?
|
Angina, Unstable | 2 | 2018 | 926 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 461 | 0.040 |
Why?
|
Proinsulin | 1 | 2019 | 135 | 0.040 |
Why?
|
Cholesterol, HDL | 2 | 2016 | 1817 | 0.040 |
Why?
|
Palliative Care | 2 | 2015 | 3607 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 655 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 848 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3224 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2024 | 613 | 0.040 |
Why?
|
Venous Pressure | 1 | 2019 | 57 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2003 | 752 | 0.040 |
Why?
|
Necrosis | 2 | 2017 | 1612 | 0.040 |
Why?
|
Prolapse | 1 | 2018 | 63 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1723 | 0.040 |
Why?
|
Hepatic Veins | 1 | 2019 | 112 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2005 | 1403 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22023 | 0.040 |
Why?
|
Chronic Disease | 4 | 2018 | 9287 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2019 | 159 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 768 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13630 | 0.040 |
Why?
|
Bicycling | 1 | 2019 | 176 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 433 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 433 | 0.040 |
Why?
|
Electromagnetic Fields | 1 | 1999 | 296 | 0.040 |
Why?
|
Calcinosis | 1 | 2006 | 1476 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2013 | 6828 | 0.040 |
Why?
|
Recurrence | 3 | 2014 | 8482 | 0.040 |
Why?
|
Germany | 1 | 2019 | 873 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 1648 | 0.040 |
Why?
|
Biopsy | 3 | 2016 | 6771 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1628 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4107 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2002 | 1257 | 0.030 |
Why?
|
Echo-Planar Imaging | 1 | 2001 | 657 | 0.030 |
Why?
|
Posture | 1 | 2001 | 953 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2004 | 3562 | 0.030 |
Why?
|
Mathematics | 1 | 1998 | 707 | 0.030 |
Why?
|
Glucosides | 1 | 2021 | 533 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5508 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3426 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2222 | 0.030 |
Why?
|
Magnetite Nanoparticles | 1 | 1997 | 316 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2016 | 212 | 0.030 |
Why?
|
Cholesterol | 1 | 2004 | 2924 | 0.030 |
Why?
|
Dextrans | 1 | 1997 | 574 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2015 | 92 | 0.030 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1180 | 0.030 |
Why?
|
Dipyridamole | 2 | 2008 | 143 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2015 | 210 | 0.030 |
Why?
|
Simvastatin | 1 | 2017 | 352 | 0.030 |
Why?
|
Capillaries | 1 | 1998 | 744 | 0.030 |
Why?
|
Principal Component Analysis | 2 | 2008 | 940 | 0.030 |
Why?
|
Minnesota | 1 | 2015 | 340 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 2014 | 94 | 0.030 |
Why?
|
Lung | 1 | 2012 | 9994 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 941 | 0.030 |
Why?
|
Survival Rate | 3 | 2014 | 12808 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5075 | 0.030 |
Why?
|
Body Weight | 2 | 2015 | 4611 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 678 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1627 | 0.030 |
Why?
|
Wound Healing | 1 | 2004 | 2788 | 0.030 |
Why?
|
Fourier Analysis | 2 | 1995 | 439 | 0.030 |
Why?
|
Troponin I | 1 | 2017 | 638 | 0.030 |
Why?
|
Heart Bypass, Right | 1 | 2013 | 75 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 311 | 0.030 |
Why?
|
Atrial Function | 1 | 2013 | 99 | 0.030 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 192 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2015 | 727 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 983 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2007 | 1578 | 0.030 |
Why?
|
Odds Ratio | 2 | 2015 | 9716 | 0.030 |
Why?
|
Body Surface Area | 1 | 2012 | 197 | 0.030 |
Why?
|
Vena Cava, Superior | 1 | 2013 | 197 | 0.020 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 79 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1784 | 0.020 |
Why?
|
Permeability | 1 | 1994 | 719 | 0.020 |
Why?
|
Diuretics | 1 | 2014 | 613 | 0.020 |
Why?
|
Magnetics | 2 | 2010 | 600 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1296 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21025 | 0.020 |
Why?
|
Protein Precursors | 1 | 2015 | 1134 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1521 | 0.020 |
Why?
|
Regression Analysis | 2 | 2011 | 6360 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1446 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 17790 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6315 | 0.020 |
Why?
|
Lipids | 2 | 2014 | 3336 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1765 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 924 | 0.020 |
Why?
|
Thermodilution | 1 | 2009 | 51 | 0.020 |
Why?
|
Creatinine | 1 | 2015 | 1903 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 199 | 0.020 |
Why?
|
Oximetry | 1 | 2012 | 461 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 546 | 0.020 |
Why?
|
Boston | 2 | 2011 | 9280 | 0.020 |
Why?
|
Primary Prevention | 1 | 2016 | 1207 | 0.020 |
Why?
|
Brain | 1 | 1995 | 26951 | 0.020 |
Why?
|
Marfan Syndrome | 1 | 2010 | 236 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7269 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1928 | 0.020 |
Why?
|
Atrial Septum | 1 | 2008 | 61 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1523 | 0.020 |
Why?
|
Water | 1 | 1994 | 1407 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1889 | 0.020 |
Why?
|
Ultrasonography | 2 | 2016 | 5961 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 1570 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2420 | 0.020 |
Why?
|
Sampling Studies | 1 | 2007 | 613 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4433 | 0.020 |
Why?
|
Radiography | 2 | 2009 | 6965 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8986 | 0.020 |
Why?
|
Computer Systems | 1 | 2006 | 470 | 0.020 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2010 | 537 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1995 | 2733 | 0.010 |
Why?
|
Survivors | 1 | 2015 | 2375 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6498 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3441 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 660 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4426 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2014 | 1518 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4357 | 0.010 |
Why?
|
Heart Septum | 1 | 2004 | 303 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1617 | 0.010 |
Why?
|
Lung Diseases | 1 | 2012 | 1915 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1352 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3790 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7806 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2635 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2475 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 505 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1474 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3528 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 897 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8803 | 0.010 |
Why?
|
Mesoderm | 1 | 2004 | 672 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6597 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 2001 | 138 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2003 | 504 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15789 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4283 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5745 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2116 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2000 | 369 | 0.010 |
Why?
|
Myoglobin | 1 | 1999 | 159 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1999 | 261 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3258 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 1432 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7064 | 0.010 |
Why?
|
Drug Residues | 1 | 1996 | 7 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2256 | 0.010 |
Why?
|
Models, Animal | 1 | 2003 | 2117 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1273 | 0.010 |
Why?
|
Dobutamine | 1 | 1996 | 116 | 0.010 |
Why?
|
Nanoparticles | 1 | 2007 | 1943 | 0.010 |
Why?
|
Phosphates | 1 | 1999 | 772 | 0.010 |
Why?
|
Stents | 1 | 2007 | 3314 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9631 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1999 | 1993 | 0.010 |
Why?
|
Cell Movement | 1 | 2004 | 5206 | 0.010 |
Why?
|
Specimen Handling | 1 | 1996 | 707 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3523 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 2025 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26181 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 1997 | 1502 | 0.010 |
Why?
|
Stroke | 1 | 2011 | 9962 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2004 | 18957 | 0.000 |
Why?
|
Kinetics | 1 | 1995 | 6377 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2004 | 11481 | 0.000 |
Why?
|